Vaxcyte, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vaxcyte, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vaxcyte, Inc. for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 7,259 | |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 24.48 | 1,361 | 33,317 | 1,408 | 2.8 K to 1.4 K (-49.15 %) |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 23.64 | 3,389 | 80,116 | 2,769 | 6.2 K to 2.8 K (-55.03 %) |
| Mar 29 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |
| Mar 23 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Option Exercise | M | 1.79 | 15,000 | 26,850 | 448,815 | |
| Mar 23 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Sell | S | 25.77 | 15,000 | 386,550 | 578,691 | 593.7 K to 578.7 K (-2.53 %) |
| Mar 23 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | President & CEO | Buy | M | 1.79 | 15,000 | 26,850 | 593,691 | 578.7 K to 593.7 K (+2.59 %) |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 199,968 | |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 27.49 | 1,487 | 40,878 | 1,562 | 3 K to 1.6 K (-48.77 %) |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 27.01 | 1,013 | 27,361 | 3,049 | 4.1 K to 3 K (-24.94 %) |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
| Mar 15 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | M | 1.79 | 2,500 | 4,475 | 21,426 | |
| Mar 15 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | S | 25.00 | 2,500 | 62,500 | 77,899 | 80.4 K to 77.9 K (-3.11 %) |
| Mar 15 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Buy | M | 1.79 | 2,500 | 4,475 | 80,399 | 77.9 K to 80.4 K (+3.21 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 0.04 | 4,750 | 190 | 12,009 | |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 25.33 | 68 | 1,722 | 1,408 | 1.5 K to 1.4 K (-4.61 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 24.34 | 1,372 | 33,394 | 1,476 | 2.8 K to 1.5 K (-48.17 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Sell | S | 23.73 | 3,310 | 78,546 | 2,848 | 6.2 K to 2.8 K (-53.75 %) |
| Mar 02 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 0.04 | 4,750 | 190 | 6,158 | 1.4 K to 6.2 K (+337.36 %) |